E-LIB Suche - Ergebnisse für: Kaufmann, Priska

1

Value of Assessing 1‐Hydroxymidazolam in Drug‐Drug Interact..:

Magliocca, Massimo ; Berger, Benjamin ; Lemoine, Vincent..
The Journal of Clinical Pharmacology. , 2024

Link: https://doi.org/10.1002/..

2

Transfer of the Dual Orexin Receptor Antagonist Daridorexan..:

Kaufmann, Priska ; Muehlan, Clemens ; Anliker‐Ort, Marion...
The Journal of Clinical Pharmacology. , 2024

Link: https://doi.org/10.1002/..

3

0100 Excretion of the Dual Orexin Receptor Antagonist Darid..:

Kaufmann, Priska ; Anliker-Ort, Marion ; Siebers, Nicholas..
SLEEP. 47 (2024) Supplement_1 - p. A44-A44 , 2024

Link: https://doi.org/10.1093/..

4

Effect of Daridorexant on the Pharmacokinetics of Midazolam..:

Zenklusen, Isabelle ; Dingemanse, Jasper ; Reh, Christian..
Drugs in R&D. 24 (2024) 1 - p. 97-108 , 2024

Link: https://doi.org/10.1007/..

5

Effect of Daridorexant on the Pharmacokinetics of P-Glycopr..:

Anliker-Ort, Marion ; Dingemanse, Jasper ; Janů, Luboš.
Clinical Drug Investigation. 43 (2023) 11 - p. 827-837 , 2023

Link: https://doi.org/10.1007/..

6

Modeling time‐delayed concentration‐QT effects with ACT‐101..:

Anliker‐Ort, Marion ; Hsin, Chih‐hsuan ; Krause, Andreas...
Pharmacology Research & Perspectives. 11 (2023) 4 - p. , 2023

Link: https://doi.org/10.1002/..

7

Evaluation of the cytochrome P450 2C19 and 3A4 inhibition p..:

Anliker‐Ort, Marion ; Dingemanse, Jasper ; Delahaye, Stephane...
Clinical and Translational Science. 16 (2023) 7 - p. 1220-1231 , 2023

Link: https://doi.org/10.1111/..

8

Effect of nivasorexant (ACT‐539313), a selective orexin‐1‐r..:

Berger, Benjamin ; Kaufmann, Priska ; Berse, Matthias...
Pharmacology Research & Perspectives. 11 (2023) 5 - p. , 2023

Link: https://doi.org/10.1002/..

9

First‐in‐human study with ACT‐1014‐6470, a novel oral compl..:

Ort, Marion ; Dingemanse, Jasper ; Hsin, Chih‐hsuan...
Basic & Clinical Pharmacology & Toxicology. , 2022

Link: https://doi.org/10.1111/..

10

Multiple‐ascending doses of ACT‐1014‐6470, an oral compleme..:

Anliker‐Ort, Marion ; Dingemanse, Jasper ; Farine, Hervé...
British Journal of Clinical Pharmacology. 89 (2022) 1 - p. 380-389 , 2022

Link: https://doi.org/10.1111/..

11

Effect of Severe Renal Impairment on Pharmacokinetics, Safe..:

Hammann‐Hänni, Anya ; Kaufmann, Priska ; Klein, Gernot..
Clinical Pharmacology in Drug Development. 12 (2022) 2 - p. 152-158 , 2022

Link: https://doi.org/10.1002/..

12

Multiple-dose clinical pharmacology of the selective orexin..:

Kaufmann, Priska ; Ort, Marion ; Golor, Georg..
Progress in Neuro-Psychopharmacology and Biological Psychiatry. 108 (2021) - p. 110166 , 2021

Link: https://doi.org/10.1016/..

13

First‐in‐human study with ACT‐539313, a novel selective ore..:

Kaufmann, Priska ; Anliker‐Ort, Marion ; Golor, Georg..
British Journal of Clinical Pharmacology. 86 (2020) 7 - p. 1377-1386 , 2020

Link: https://doi.org/10.1111/..

14

Multiple-Ascending Dose Study in Healthy Subjects to Assess..:

Richard, Muriel ; Kaufmann, Priska ; Ort, Marion..
CNS Drugs. 34 (2020) 3 - p. 311-323 , 2020

Link: https://doi.org/10.1007/..

15

Impact of the Selective Orexin‐1 Receptor Antagonist ACT‐53..:

Berger, Benjamin ; Kaufmann, Priska ; Koch, Annelize.
The Journal of Clinical Pharmacology. 60 (2020) 7 - p. 931-941 , 2020

Link: https://doi.org/10.1002/..